RxDoctor Payments Data

Asante Mendes, MD

Psychiatry · Farmington, CTNPI 1114109212

Payments from drug & device makers

$959in general payments, 2019–2025

Across 48 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanir Pharmaceuticals, Inc.$264
  • Otsuka America Pharmaceutical, Inc.$252
  • Neurocrine Biosciences, Inc.$118
  • Acadia Pharmaceuticals Inc$91
  • Urovant Sciences Inc$49
  • Lundbeck LLC$40
  • plus $145 from 6 others

What the payments were for

  • Food & beverage$92997%
  • Education$303%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$959 in reported general payments places this provider in the 75th percentile of 644 psychiatry providers in Connecticut.

See all psychiatry providers in Connecticut

Medicare billing

Part B allowed, 2024
$268,433
Medicare patients
561
Services billed
2,712

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuboxoneBuprenorphine Hcl/Naloxone Hcl23$12,966
Memantine Hcl40$1,604
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl44$1,503
Mirtazapine55$1,147
Divalproex Sodium25$1,059
Trazodone Hcl45$762
Lorazepam36$715
Quetiapine Fumarate25$659
Venlafaxine Hcl ErVenlafaxine Hcl13$602
Clonazepam50$559
Escitalopram Oxalate65$484
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine16$329
Duloxetine Hcl17$305
Bupropion XlBupropion Hcl18$257
Sertraline Hcl16$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Suboxone$36$12,96623 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 644 psychiatry providers in Connecticut.

Other psychiatry in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →